Proscia is a leading digital pathology software company revolutionizing the field of computational pathology with its AI-powered Concentriq® platform. Designed for anatomic pathology, life sciences, and precision medicine, Concentriq enables laboratories to transition from traditional glass slides to a fully digital workflow, enhancing diagnostic accuracy and efficiency. With FDA 510(k) clearance for Concentriq AP-Dx, Proscia supports primary diagnosis, facilitating faster and more reliable cancer diagnostics. The platform's AI applications, including Concentriq Embeddings, accelerate biomarker discovery and drug development by providing real-time insights from whole slide images. Trusted by 16 of the top 20 pharmaceutical companies, Proscia's solutions are instrumental in advancing research and clinical practices globally. By integrating seamlessly with existing laboratory information systems and supporting remote collaboration, Proscia empowers pathologists to deliver high-quality care and drive the future of precision medicine.
